EGAS00001001697-sc-20170317 - samples

ABSTRACT: This study involves mutagenizing C32, a melanoma cell line, with ENU to identify those mutations which engender resistance to a targeted treatment.

PROVIDER: EGAD00001003239 | EGA |

REPOSITORIES: EGA